{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for angiotensin root_Display\ Name in Display Name (approximate match)
Status:
Possibly Marketed Outside US
Class:
PROTEIN
Status:
Other
Class:
POLYMER
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2001)
Source URL:
First approved in 2001
Source:
21 CFR 352
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Excipient
Source:
38mg ORAL TABLET
Source URL:
Class:
G1 SPECIFIED SUBSTANCE
Status:
Excipient
Class:
G1 SPECIFIED SUBSTANCE
Status:
Excipient
Class:
G1 SPECIFIED SUBSTANCE
Status:
Excipient
Class:
G1 SPECIFIED SUBSTANCE
Status:
Excipient
Class:
G1 SPECIFIED SUBSTANCE